CL2008000786A1 - Composicion farmaceutica proliposomal que comprende un concentrado de: un lipido formador de membranas con uno o mas fosfolipidos saturado o no saturado, un agente estabilizador de membrana seleccionado de un compuesto esterol y un vehiculo como un s - Google Patents
Composicion farmaceutica proliposomal que comprende un concentrado de: un lipido formador de membranas con uno o mas fosfolipidos saturado o no saturado, un agente estabilizador de membrana seleccionado de un compuesto esterol y un vehiculo como un sInfo
- Publication number
- CL2008000786A1 CL2008000786A1 CL200800786A CL2008000786A CL2008000786A1 CL 2008000786 A1 CL2008000786 A1 CL 2008000786A1 CL 200800786 A CL200800786 A CL 200800786A CL 2008000786 A CL2008000786 A CL 2008000786A CL 2008000786 A1 CL2008000786 A1 CL 2008000786A1
- Authority
- CL
- Chile
- Prior art keywords
- saturated
- membrane
- concentrate
- vehicle
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1277—Processes for preparing; Proliposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN590DE2007 | 2007-03-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2008000786A1 true CL2008000786A1 (es) | 2008-09-26 |
Family
ID=39620132
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL200800786A CL2008000786A1 (es) | 2007-03-19 | 2008-03-18 | Composicion farmaceutica proliposomal que comprende un concentrado de: un lipido formador de membranas con uno o mas fosfolipidos saturado o no saturado, un agente estabilizador de membrana seleccionado de un compuesto esterol y un vehiculo como un s |
Country Status (8)
Country | Link |
---|---|
US (1) | US20090017105A1 (es) |
EP (1) | EP2146692A1 (es) |
AR (1) | AR065805A1 (es) |
AU (1) | AU2008227852B2 (es) |
CA (1) | CA2681302C (es) |
CL (1) | CL2008000786A1 (es) |
TW (1) | TWI355946B (es) |
WO (1) | WO2008114274A1 (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8476010B2 (en) | 2003-07-10 | 2013-07-02 | App Pharmaceuticals Llc | Propofol formulations with non-reactive container closures |
US20140335166A1 (en) * | 2013-05-08 | 2014-11-13 | Michael W. Fountain | Methods of Making and Using Nano Scale Particles |
KR101066197B1 (ko) * | 2009-04-06 | 2011-09-20 | 한국생명공학연구원 | 코엔자임 q10 나노입자, 그 제조방법 및 상기 나노입자를 포함하는 조성물 |
PL214538B1 (pl) * | 2009-05-28 | 2013-08-30 | P P F Hasco Lek Spolka Akcyjna | Kompozycja liposomowa zawierajaca naproksen i sposób wytwarzania kompozycji liposomowej zawierajacej naproksen |
US10143652B2 (en) | 2009-09-23 | 2018-12-04 | Curirx Inc. | Methods for the preparation of liposomes |
US9402812B2 (en) * | 2009-09-23 | 2016-08-02 | Indu JAVERI | Methods for the preparation of liposomes |
PT2508170E (pt) | 2009-12-03 | 2015-10-16 | Shanghai Hengrui Pharm Co Ltd | Lipossoma de irinotecano ou o seu cloridrato e seu método de preparação |
BR112012028037A2 (pt) | 2010-05-03 | 2016-08-02 | Teikoku Pharma Usa Inc | formulação de pró-emulsão líquida de taxano não aquosa, métodos para administrar um taxano a um paciente e para fabricar uma formulação de pró-emulsão de taxano, composição de emulsão de taxano, e, kit |
CN104780914B (zh) | 2012-05-09 | 2018-02-09 | 健康科学西部大学 | 前体脂质体睾酮制剂 |
CN104427976B (zh) | 2012-05-10 | 2018-04-24 | 佩因拉佛姆有限公司 | 疏水的活性成分的储库制剂及其制备方法 |
JO3685B1 (ar) | 2012-10-01 | 2020-08-27 | Teikoku Pharma Usa Inc | صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها |
CN103768018A (zh) * | 2012-10-17 | 2014-05-07 | 南京绿叶思科药业有限公司 | 一种卡巴他赛脂质体注射剂及其制备方法 |
US20150132369A1 (en) * | 2013-11-09 | 2015-05-14 | Exir Nano Sina Company | Nanoliposomal cyclosorin formulations for immunosuppresion and methods for the production thereof |
JP2018507227A (ja) * | 2015-03-03 | 2018-03-15 | キュアポート インコーポレイテッド | 二薬搭載リポソーム医薬製剤 |
EP3265059A4 (en) * | 2015-03-03 | 2018-08-29 | Cureport Inc. | Combination liposomal pharmaceutical formulations |
TWI724018B (zh) | 2015-08-20 | 2021-04-11 | 英商益普生生物製藥有限公司 | 用於癌症治療之組合療法 |
CN105055322A (zh) * | 2015-09-02 | 2015-11-18 | 厦门市壳聚糖生物科技有限公司 | 甲氨喋呤磷脂复合物、其纳米粒子及其靶向缓释制剂三者的制备方法 |
EP3360577A4 (en) * | 2015-10-07 | 2019-06-12 | Ensuiko Sugar Refining Co., Ltd. | LIPOSOME COMPRISING A TAXANE COMPOUND |
WO2017120592A1 (en) * | 2016-01-08 | 2017-07-13 | Western University Of Health Sciences | Proliposomal testosterone undecanoate formulations |
CN107362142B (zh) * | 2016-05-13 | 2023-04-25 | 山东新时代药业有限公司 | 一种氟维司群脂质体注射液及其制备方法 |
AU2017324718B2 (en) * | 2016-09-09 | 2022-09-29 | Irisys, Inc. | Lipsomal anticancer compositions |
PL3532067T3 (pl) | 2016-10-28 | 2022-08-16 | Les Laboratoires Servier | Preparat liposomalny |
PE20191653A1 (es) * | 2016-11-11 | 2019-11-07 | Univ Western Health Sciences | Metodos para tratar carcinomas uroteliales del tracto superior |
CN108926533B (zh) * | 2017-05-24 | 2022-03-25 | 江苏天士力帝益药业有限公司 | 一种替西罗莫司脂质体及其制备方法 |
WO2019082139A1 (en) * | 2017-10-27 | 2019-05-02 | Shilpa Medicare Limited | LIPOSOMAL FINGOLIMOD HYDROCHLORIDE INJECTION |
AU2018374593B2 (en) * | 2017-11-30 | 2021-09-09 | Shilpa Medicare Limited | Composition of docetaxel liposomal injection with high drug loading |
CN110368500B (zh) * | 2019-07-12 | 2020-06-30 | 浙江大学 | 一种两亲性共聚物药物前体、制备方法以及包载钙泊三醇的纳米颗粒 |
CN112076158B (zh) * | 2020-08-28 | 2023-12-08 | 西南民族大学 | 一种治疗慢性肾炎的脂质体-纳米粒复合体 |
CN113181113A (zh) * | 2021-04-28 | 2021-07-30 | 四川科伦药业股份有限公司 | 一种甲硝唑氯化钠注射液的制备方法 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4744989A (en) * | 1984-02-08 | 1988-05-17 | E. R. Squibb & Sons, Inc. | Method of preparing liposomes and products produced thereby |
JPH0753661B2 (ja) * | 1984-03-08 | 1995-06-07 | フアレス フアーマスーチカル リサーチ エヌブイ | プロ―リポソーム組成物及びリポソームの水性分散物を作る方法 |
US4837028A (en) * | 1986-12-24 | 1989-06-06 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5262168A (en) * | 1987-05-22 | 1993-11-16 | The Liposome Company, Inc. | Prostaglandin-lipid formulations |
CA2050679C (en) * | 1989-03-31 | 1998-09-22 | Francis C. Szoka, Jr. | Preparation of liposome and lipid complex compositions |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
US5498420A (en) * | 1991-04-12 | 1996-03-12 | Merz & Co. Gmbh & Co. | Stable small particle liposome preparations, their production and use in topical cosmetic, and pharmaceutical compositions |
ES2154680T3 (es) * | 1993-07-08 | 2001-04-16 | Liposome Co Inc | Metodo para controlar el tamaño de los liposomas. |
AR002009A1 (es) * | 1994-12-22 | 1998-01-07 | Astra Ab | Composicion farmaceutica, procedimiento para la manufactura de un polvo de proliposoma como el utilizado en dicha composicion, procedimiento para lamanufactura de dicha composicion, uso de dicha composicion farmaceutica en la manufactura de un medicamento y dispositivo inhalador de polvo seco. |
US5753262A (en) * | 1995-06-07 | 1998-05-19 | Aronex Pharmaceuticals, Inc. | Cationic lipid acid salt of 3beta N- (N', N'-dimethylaminoethane) - carbamoyl!cholestrol and halogenated solvent-free preliposomal lyophilate thereof |
GB2331924A (en) * | 1997-12-08 | 1999-06-09 | Phares Pharm Res Nv | Lipid compositions and their use |
CN1196474C (zh) * | 1999-10-01 | 2005-04-13 | 利普森技术有限公司 | 脂质体包封的dna口服疫苗 |
US6761901B1 (en) * | 2000-05-02 | 2004-07-13 | Enzrel Inc. | Liposome drug delivery |
ATE444062T1 (de) * | 2002-06-26 | 2009-10-15 | Medigene Ag | Herstellung einer kationisch liposomalen zubereitung, einen lipophilen wirkstoff enthaltend |
CA2506749A1 (en) * | 2002-11-26 | 2004-06-10 | Gilead Sciences, Inc. | Method of drug loading in liposomes by gradient |
MXPA05008489A (es) * | 2003-02-11 | 2005-10-18 | Neopharm Inc | Procedimiento de fabricacion para preparaciones liposomicas. |
EP1666486A4 (en) * | 2003-09-03 | 2006-12-06 | Kyowa Hakko Kogyo Kk | MODIFIED COMPOUND USING A GLYCEROL DERIVATIVE |
KR101462819B1 (ko) * | 2004-05-03 | 2014-11-21 | 헤르메스 바이오사이언스, 인코포레이티드 | 약물 전달에 유용한 리포좀 |
AU2006321796A1 (en) * | 2005-12-08 | 2007-06-14 | Wyeth | Liposomal compositions |
US9814672B2 (en) * | 2007-03-09 | 2017-11-14 | Susan T. Laing | Echogenic vehicle for clinical delivery of plasminogen activator and other fibrin-binding therapeutics to thrombi |
-
2008
- 2008-01-04 EP EP08702731A patent/EP2146692A1/en not_active Withdrawn
- 2008-01-04 CA CA2681302A patent/CA2681302C/en not_active Expired - Fee Related
- 2008-01-04 AU AU2008227852A patent/AU2008227852B2/en not_active Ceased
- 2008-01-04 WO PCT/IN2008/000003 patent/WO2008114274A1/en active Search and Examination
- 2008-03-10 TW TW097108323A patent/TWI355946B/zh not_active IP Right Cessation
- 2008-03-11 US US12/045,958 patent/US20090017105A1/en not_active Abandoned
- 2008-03-18 CL CL200800786A patent/CL2008000786A1/es unknown
- 2008-03-19 AR ARP080101166A patent/AR065805A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU2008227852B2 (en) | 2011-02-24 |
CA2681302C (en) | 2013-07-23 |
TWI355946B (en) | 2012-01-11 |
US20090017105A1 (en) | 2009-01-15 |
TW200904483A (en) | 2009-02-01 |
AR065805A1 (es) | 2009-07-01 |
AU2008227852A1 (en) | 2008-09-25 |
EP2146692A1 (en) | 2010-01-27 |
WO2008114274A1 (en) | 2008-09-25 |
CA2681302A1 (en) | 2008-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008000786A1 (es) | Composicion farmaceutica proliposomal que comprende un concentrado de: un lipido formador de membranas con uno o mas fosfolipidos saturado o no saturado, un agente estabilizador de membrana seleccionado de un compuesto esterol y un vehiculo como un s | |
ECSP11010822A (es) | 4-fenil-1h-pirazoles insecticidas | |
UY32327A (es) | Antagonistas de receptores de ácido lisofosfatídico | |
CL2008000531A1 (es) | Compuestos derivados de heterociclos, inhibidores de la aspartilproteasa; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de enfermedades cardiovasculares, cognitivas y neurodegenerativas tales como la enfermeda | |
ECSP13011139A (es) | Anticuerpos contra la angiopoyetina 2 humana | |
CL2008000562A1 (es) | Uso de compuestos derivados de diaminopirimidina como fungicidas; agente para combatir microorganismos no deseados que contiene a dichos compuestos; procedimiento para combatir microorganismos no deseados; procedimiento de preparacion de dichos agent | |
CL2007001997A1 (es) | Compuestos derivados de tiofeno, agentes inmunomoduladores; composicion farmaceutica que los comprende; y su uso para tratar o prevenir enfermedades o trastornos asociados con un sistema inmunologico activado, tales como rechazo de organos transplant | |
CL2015001486A1 (es) | Composición que comprende agentes de control biológico. | |
CO6680708A2 (es) | Compuesto modulares de estrógenos y composiciones que comprenden los mismos | |
CL2007003804A1 (es) | Compuestos derivados de indazol; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar condiciones inflamatorias, tales como asma, epoc. | |
NI201000055A (es) | 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa. | |
BR112014029122A2 (pt) | composições que compreendem um agente de controle biológico e um inseticida | |
BR112014029222A2 (pt) | composições que compreendem um agente de controle biológico e um inseticida | |
BRPI0923589A2 (pt) | uso de uma composição espumável essencialmente livre de ingredientes farmaceuticamente ativos para o tratamento da pele humana. | |
BR112014029118A2 (pt) | composições que compreendem um agente de controle biológico e um inseticida | |
BRPI0916208A2 (pt) | membrana híbrida orgânica-inorgânica microporosa baseado em sílica, membrana compósita, e, uso de uma membrana | |
BR112015021908A8 (pt) | implante, método de realizar uma ostomia, e método de fabricar um implante | |
BRPI1013259B8 (pt) | moduladores lxr | |
CL2008002984A1 (es) | Composicion farmaceutica que comprende micofenolato sodico y su uso para el tratamiento y/o prevencion en enfermedades autoinmunes tales como el rechazo de aloinjertos o xenoinjertos de organos, celulas o tejidos y como antiinflamatorio. | |
BRPI0914410A2 (pt) | composição de polidesoxirribonucleotídeo injetável para o tratamento de doenças osteoarticulares. | |
CR20110660A (es) | Mezclas fungicidas | |
ECSP088689A (es) | NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS | |
BR112013000706A2 (pt) | reforço tendo uma estrutura de três camadas e emplastro aquoso usando o reforço | |
SV2009003429A (es) | Derivados de 7-alquinil-1,8-naftiridonas, su preparacion y su aplicacion en terapeutica | |
CL2008000217A1 (es) | Combinaciones de compuestos activos que comprenden la formononetina y al menos un compuesto activo; uso de dicha combinacion para controlar hongos fitopatogenos no deseados; y procedimiento para controlar hongos fitopatogenos no deseados. |